A way out of the Brexit morass?
09 May 2019 – 14:15 | No Comment

Brexit-bound Britain will participate in this month’s European Parliament (EP) election, unless UK prime minister, Theresa May, and opposition leader, Jeremy Corbyn, manage to push the thrice-rejected EU withdrawal agreement through the House of Commons …

Read the full story »
Health

Energy & Environment

Circular Economy

Climate Change

Security

Home » Archive by Tags

Articles tagged with: prostate cancer

POLICY PRESCRIPTIONS: Fixing diagnosis and treatment of prostate cancer
30 Sep 2015 – 09:00
POLICY PRESCRIPTIONS: Fixing diagnosis and treatment of prostate cancer

Prostate Cancer (PCa) is one of the most urgent medical problems in adult males and is the most widespread and third deadliest cancer for men in the European Union. It is very well known that …

Improving outcomes of advanced prostate cancer in Europe: a call to action
28 Sep 2015 – 09:10
Improving outcomes of advanced prostate cancer in Europe: a call to action

Differences in early diagnosis and management of patients with high-risk localized disease can play an important role in cancer outcomes, says Christine Geffriaud-Ricouard, MD, Medical Director, Sanofi Oncology

Prostate cancer is the most frequently diagnosed cancer …

Identifying patients with early prostate cancer
28 Sep 2015 – 09:07
Identifying patients with early prostate cancer

As newly diagnosed men can have either aggressive or indolent tumors, Dr Colin R W Hayward, European Medical Director, Myriad Genetics says There is a clear need to further personalize initial management approaches for men …

Epidemiology of prostate cancer in Europe
28 Sep 2015 – 09:07

By Emanuele Crocetti, MD, Public Health Policy Support Unit, Institute for Health and Consumer Protection at European Commission
Reliable information on the burden and outcome of cancer in a population are provided by population-based cancer registries …

Improving prostate cancer treatment
28 Sep 2015 – 09:07
Improving prostate cancer treatment

Multiparametric MR imaging in conjunction with biomarker and genomic data will hopefully generate a cancer risk map score for the entire prostate. Prof. Dr. med. Mathias Goyen says this obviates the need for invasive biopsy …

Refining diagnostic and treatment protocols for prostate cancer
28 Sep 2015 – 09:05
Refining diagnostic and treatment  protocols for prostate cancer

Since most prostate cancers develop slowly and disease progression depends on tumour characteristics, Prof.Hein Van Poppel says refining treatment becomes essential
Prostate cancer (PCa) is the third most commonly occurring cancer in European men. The trend …

A supplemental blood test for the detection of prostate cancer
28 Sep 2015 – 09:05
A supplemental blood test for the detection of prostate cancer

There are several benefits to both patient and payer for a PSA supplemental laboratory developed test. Dr.Howard Urnovitz from Chronix Biomedical says that it makes the entire approach of screening for prostate cancer more accurate

Canvassing for a European semester for healthcare policy
28 Sep 2015 – 09:05
Canvassing for a European semester for healthcare policy

Similar to an economic semester for growth,  Alojz Peterle, President of the MEPs Against Cancer (MAC) group calls for a semester for health
Despite being an essential part of economic and social success, health systems in …

Fighting Prostate Cancer: a European Union Challenge
15 Apr 2014 – 15:46
Fighting Prostate Cancer: a European Union Challenge

By Isabel De la Mata, Principal Adviser with special interest in Health, European Commission
Male cancer patterns in the European Union are changing; lung cancer is declining but prostate cancer is increasing, affecting around one million …

New Initiative on Prostate Cancer in Europe
15 Apr 2014 – 15:28
New Initiative on Prostate Cancer in Europe

 
By Gunnar Schroefel, Bayer Pharma AG, Global Advocacy Lead Oncology
Bayer HealthCare is a global company with a strong commitment to developing and delivering new treatments in cancer.  In particular, it is active in the development …